# Novo Nordisk (Denmark)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/novo-nordisk-denmark/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 35.4 |
| Citations | 1,516,992 |
| City | Copenhagen |
| Country | DK |
| Description | Novo Nordisk (Denmark) is a research organisation in Copenhagen, DK. OpenAlex records 13,546 works and 1,516,992 citations for it. 3,664 researchers list it as their most recent affiliation. |
| Homepage | http://www.novonordisk.com/ |
| OpenAlex ID | https://openalex.org/I189090001 |
| Region | Capital Region |
| Researchers | 3,664 |
| ROR ID | https://ror.org/0435rc536 |
| Type | company |
| Works | 13,546 |

## University papers

Showing 12 of 101.

- [Empagliflozin in Heart Failure with a Preserved Ejection Fraction](https://scholariq.org/papers/empagliflozin-in-heart-failure-with-a-preserved-ejection-fraction/)
- [Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes](https://scholariq.org/papers/semaglutide-and-cardiovascular-outcomes-in-obesity-without-diabetes/)
- [Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society](https://scholariq.org/papers/familial-hypercholesterolaemia-is-underdiagnosed-and-undertreated-in-the-general/)
- [Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes](https://scholariq.org/papers/oral-semaglutide-and-cardiovascular-outcomes-in-patients-with-type-2-diabetes/)
- [Cardiovascular Disease in Chronic Kidney Disease](https://scholariq.org/papers/cardiovascular-disease-in-chronic-kidney-disease/)
- [Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes](https://scholariq.org/papers/effects-of-semaglutide-on-chronic-kidney-disease-in-patients-with-type-2/)
- [Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity](https://scholariq.org/papers/semaglutide-in-patients-with-heart-failure-with-preserved-ejection-fraction-and/)
- [Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management](https://scholariq.org/papers/statin-associated-muscle-symptoms-impact-on-statin-therapy-european/)
- [Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial](https://scholariq.org/papers/semaglutide-2-4-mg-once-a-week-in-adults-with-overweight-or-obesity-and-type-2/)
- [Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk](https://scholariq.org/papers/effect-of-linagliptin-vs-placebo-on-major-cardiovascular-events-in-adults-with/)
- [Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society](https://scholariq.org/papers/homozygous-familial-hypercholesterolaemia-new-insights-and-guidance-for/)
- [Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment](https://scholariq.org/papers/familial-hypercholesterolaemia-in-children-and-adolescents-gaining-decades-of/)

## University researchers

- [Ole Kleist Jeppesen](https://scholariq.org/researchers/ole-kleist-jeppesen/)
- [S. B. Andersen](https://scholariq.org/researchers/s-b-andersen/)
- [Florian M.M. Baeres](https://scholariq.org/researchers/florian-m-m-baeres/)
- [Manuel Mayrdorfer](https://scholariq.org/researchers/manuel-mayrdorfer/)
- [Charlotte Bisgaard](https://scholariq.org/researchers/charlotte-bisgaard/)
- [Christopher Lübker](https://scholariq.org/researchers/christopher-lubker/)
- [Nicolas Belmar](https://scholariq.org/researchers/nicolas-belmar/)
- [Minh Chau Tran](https://scholariq.org/researchers/minh-chau-tran/)

## University top topics

Showing 8 of 24.

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Hemophilia Treatment and Research](https://scholariq.org/topics/hemophilia-treatment-and-research/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Quantum Chromodynamics and Particle Interactions](https://scholariq.org/topics/quantum-chromodynamics-and-particle-interactions/)
- [Diabetes and associated disorders](https://scholariq.org/topics/diabetes-and-associated-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.